Cargando…

A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

BACKGROUND: Antibacterial therapy is frequently used in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) without evidence of bacterial infection, prompting concerns about increased antimicrobial resistance (AMR). We evaluated trends in AMR before and during the SARS-CoV-2 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauer, Karri A, Puzniak, Laura A, Yu, Kalvin C, Klinker, Kenneth P, Watts, Janet A, Moise, Pamela A, Finelli, Lyn, Ai, ChinEn, Gupta, Vikas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619740/ https://www.ncbi.nlm.nih.gov/pubmed/36381612 http://dx.doi.org/10.1093/ofid/ofac537

Ejemplares similares

Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation
por: Bauer, Karri A., et al.
Publicado: (2022)

Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020
por: Puzniak, Laura, et al.
Publicado: (2021)

Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)
por: Bauer, Karri A., et al.
Publicado: (2023)

A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves
por: Puzniak, Laura A., et al.
Publicado: (2023)

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19
por: Puzniak, Laura, et al.
Publicado: (2021)

379. Epidemiology of Antimicrobial Use Among SARS-CoV-2 Positive and Negative Admissions in the US: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2020)

221. Evaluation of Rates of Culture Positive Blood Stream Pathogens Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2021)

373. Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2020)

Trends in Streptococcus pneumoniae Antimicrobial Resistance in US Children: A Multicenter Evaluation
por: Mohanty, Salini, et al.
Publicado: (2023)

A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Streptococcus pneumoniae Isolates From Adults in the United States
por: Mohanty, Salini, et al.
Publicado: (2022)

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020
por: Finelli, Lyn, et al.
Publicado: (2021)

156. Evaluation of Trends in Antimicrobial Use and Proportion of Culture Positive Gram-Negative/Gram-Positive Pathogens Comparing Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2021)

398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States
por: Bauer, Karri A, et al.
Publicado: (2021)

Antibiotic Resistance Patterns and Association With the Influenza Season in the United States: A Multicenter Evaluation Reveals Surprising Associations Between Influenza Season and Resistance in Gram-Negative Pathogens
por: Gupta, Vikas, et al.
Publicado: (2022)

2166. Real-world susceptibilities to newer antibiotics in Enterobacterales and Pseudomonas aeruginosa including carbapenem non-susceptible and multi-drug resistant isolates : A multicenter analysis
por: Riccobene, Todd, et al.
Publicado: (2023)

1931. Real-world evaluation of adequacy of empiric and definitive therapy in carbapenem susceptible and non-susceptible Enterobacterales and Pseudomonas aeruginosa by time to culture result: A multicenter analysis
por: Riccobene, Todd, et al.
Publicado: (2023)

180. Multicenter Analysis of Adequacy of Empiric and Definitive Therapy by Time to Culture Result in Hospitalized Patients with Blood Culture Positive for Carbapenem Resistant and Susceptible Enterobacterales and Pseudomonas aeruginosa
por: Cooper, Lauren, et al.
Publicado: (2023)

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Hart, Delaney E, et al.
Publicado: (2021)

A multicenter analysis of inpatient antibiotic use during the 2015–2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship
por: Yu, Kalvin C., et al.
Publicado: (2022)

Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals
por: Yu, Kalvin C., et al.
Publicado: (2022)

A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011–2020
por: Dunne, Michael W., et al.
Publicado: (2022)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Before Coronavirus Disease 2019 Vaccination Among Children 0–4 Years and Their Household Members in the SEARCh Study
por: Garcia Quesada, Maria, et al.
Publicado: (2022)

A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints
por: Gupta, Vikas, et al.
Publicado: (2022)

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
por: Kabbani, Dima, et al.
Publicado: (2023)

171. A Multicenter Analysis of Inpatient Antibiotic Use During the 2015-2019 Influenza Season in the US: Untapped Opportunities for Antimicrobial Stewardship
por: Amiche, Amine, et al.
Publicado: (2021)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Zasowski, Evan J, et al.
Publicado: (2021)

Invasive Scedosporium and Lomentospora prolificans Infections in Australia: A Multicenter Retrospective Cohort Study
por: Neoh, Chin Fen, et al.
Publicado: (2023)

The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network
por: Zisis, Sokratis N, et al.
Publicado: (2022)

Prevalence of Hospital-Onset Bacteremia Pre- and Post-Implementation of a Needleless Blood Sampling Device From Existing Peripheral Catheters
por: Yu, Kalvin C., et al.
Publicado: (2023)

Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: A multicenter study
por: Son, Hyo-Ju, et al.
Publicado: (2021)

Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study
por: Oi, Issei, et al.
Publicado: (2021)

Candidemia Among Coronavirus Disease 2019 Patients in Turkey Admitted to Intensive Care Units: A Retrospective Multicenter Study
por: Arastehfar, Amir, et al.
Publicado: (2022)

Detection of Viral Infection and Bacterial Coinfection and Superinfection in Coronavirus Disease 2019 Patients Presenting to the Emergency Department Using the 29-mRNA Host Response Classifier IMX-BVN-3: A Multicenter Study
por: Bauer, Wolfgang, et al.
Publicado: (2022)

Clinical Features and Outcomes of Coronavirus Disease 2019 Among People With Human Immunodeficiency Virus in the United States: A Multicenter Study From a Large Global Health Research Network (TriNetX)
por: Yendewa, George A, et al.
Publicado: (2021)

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
por: Mozaffari, Essy, et al.
Publicado: (2021)

Lung Abnormalities in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: An Analysis of Paired Computed Tomography Scans Before and After Infection
por: Iversen, Katrine K, et al.
Publicado: (2022)

Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
por: Strahm, Carol, et al.
Publicado: (2022)

Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study
por: Gottlieb, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l8v70c91iosq4ctuvb12tbelo7